These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 29440472)

  • 1. Response by Singfer and Defreyne to Letter Regarding Article, "Unruptured Brain Arteriovenous Malformations: Primary ONYX Embolization in ARUBA (A Randomized Trial of Unruptured Brain Arteriovenous Malformations)-Eligible Patients".
    Singfer U; Defreyne L
    Stroke; 2018 Mar; 49(3):e137. PubMed ID: 29440472
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter by Liu and Chen Regarding Article, "Unruptured Brain Arteriovenous Malformations: Primary ONYX Embolization in ARUBA (A Randomized Trial of Unruptured Brain Arteriovenous Malformations)-Eligible Patients".
    Liu F; Chen J
    Stroke; 2018 Mar; 49(3):e136. PubMed ID: 29440473
    [No Abstract]   [Full Text] [Related]  

  • 3. Unruptured Brain Arteriovenous Malformations: Primary ONYX Embolization in ARUBA (A Randomized Trial of Unruptured Brain Arteriovenous Malformations)-Eligible Patients.
    Singfer U; Hemelsoet D; Vanlangenhove P; Martens F; Verbeke L; Van Roost D; Defreyne L
    Stroke; 2017 Dec; 48(12):3393-3396. PubMed ID: 29114088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment outcomes of unruptured arteriovenous malformations with a subgroup analysis of ARUBA (A Randomized Trial of Unruptured Brain Arteriovenous Malformations)-eligible patients.
    Nerva JD; Mantovani A; Barber J; Kim LJ; Rockhill JK; Hallam DK; Ghodke BV; Sekhar LN
    Neurosurgery; 2015 May; 76(5):563-70; discussion570; quiz 570. PubMed ID: 25635891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of Unruptured Brain Arteriovenous Malformations: A Single-Center Experience of 86 Patients and a Critique of the A Randomized Trial of Unruptured Brain Arteriovenous Malformations (ARUBA) Trial.
    Link TW; Winston G; Schwarz JT; Lin N; Patsalides A; Gobin P; Pannullo S; Stieg PE; Knopman J
    World Neurosurg; 2018 Dec; 120():e1156-e1162. PubMed ID: 30218805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment and outcomes of ARUBA-eligible patients with unruptured brain arteriovenous malformations at a single institution.
    Rutledge WC; Abla AA; Nelson J; Halbach VV; Kim H; Lawton MT
    Neurosurg Focus; 2014 Sep; 37(3):E8. PubMed ID: 25175446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microsurgery for ARUBA Trial (A Randomized Trial of Unruptured Brain Arteriovenous Malformation)-Eligible Unruptured Brain Arteriovenous Malformations.
    Wong J; Slomovic A; Ibrahim G; Radovanovic I; Tymianski M
    Stroke; 2017 Jan; 48(1):136-144. PubMed ID: 27856955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of microsurgical excision of unruptured brain arteriovenous malformations in ARUBA-eligible patients.
    Javadpour M; Al-Mahfoudh R; Mitchell PS; Kirollos R
    Br J Neurosurg; 2016 Dec; 30(6):619-622. PubMed ID: 27172987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intervention for A randomized trial of unruptured brain arteriovenous malformations (ARUBA) - Eligible patients: An evidence-based review.
    Hong CS; Peterson EC; Ding D; Sur S; Hasan D; Dumont AS; Chalouhi N; Jabbour P; Starke RM
    Clin Neurol Neurosurg; 2016 Nov; 150():133-138. PubMed ID: 27656780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereotactic Radiosurgery for ARUBA (A Randomized Trial of Unruptured Brain Arteriovenous Malformations)-Eligible Spetzler-Martin Grade I and II Arteriovenous Malformations: A Multicenter Study.
    Ding D; Starke RM; Kano H; Mathieu D; Huang PP; Kondziolka D; Feliciano C; Rodriguez-Mercado R; Almodovar L; Grills IS; Silva D; Abbassy M; Missios S; Barnett GH; Lunsford LD; Sheehan JP
    World Neurosurg; 2017 Jun; 102():507-517. PubMed ID: 28344176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multimodality Management of Spetzler-Martin Grade 3 Brain Arteriovenous Malformations with Subgroup Analysis.
    Abecassis IJ; Nerva JD; Feroze A; Barber J; Ghodke BV; Kim LJ; Sekhar LN
    World Neurosurg; 2017 Jun; 102():263-274. PubMed ID: 28323192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment Outcomes of A Randomized Trial of Unruptured Brain Arteriovenous Malformation-Eligible Unruptured Brain Arteriovenous Malformation Patients.
    Lang M; Moore NZ; Rasmussen PA; Bain MD
    Neurosurgery; 2018 Sep; 83(3):548-555. PubMed ID: 29040773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment Outcomes of Endovascular Embolization Only in Patients with Unruptured Brain Arteriovenous Malformations: A Subgroup Analysis of ARUBA (A Randomized Trial of Unruptured Brain Arteriovenous Malformations).
    Qureshi AI; Saeed O; Sahito S; Lobanova I; Liaqat J; Siddiq F; Gomez CR
    AJNR Am J Neuroradiol; 2020 Apr; 41(4):676-680. PubMed ID: 32115419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current surgical results with low-grade brain arteriovenous malformations.
    Potts MB; Lau D; Abla AA; Kim H; Young WL; Lawton MT;
    J Neurosurg; 2015 Apr; 122(4):912-20. PubMed ID: 25658789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain Arteriovenous Malformations: Status of Open Surgery after A Randomized Trial of Unruptured Brain Arteriovenous Malformations.
    Luther E; Govindarajan V; McCarthy DJ; Burks J; Lu V; Ramsay I; Silva M; Starke RM
    Neurosurg Clin N Am; 2022 Oct; 33(4):443-448. PubMed ID: 36229131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-blinded, randomised trial.
    Mohr JP; Parides MK; Stapf C; Moquete E; Moy CS; Overbey JR; Al-Shahi Salman R; Vicaut E; Young WL; Houdart E; Cordonnier C; Stefani MA; Hartmann A; von Kummer R; Biondi A; Berkefeld J; Klijn CJ; Harkness K; Libman R; Barreau X; Moskowitz AJ;
    Lancet; 2014 Feb; 383(9917):614-21. PubMed ID: 24268105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microsurgery for Unruptured Cerebral Arteriovenous Malformations in the National Inpatient Sample is More Common Post-ARUBA.
    Birnbaum LA; Straight M; Hegde S; Lacci JV; de Leonni Stanonik M; Mascitelli JR; McDougall CM; Caron JR
    World Neurosurg; 2020 May; 137():e343-e346. PubMed ID: 32032786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "ARUBA" Aftermath: Subsequent Studies and Current Management of Unruptured Arteriovenous Malformations.
    Feghali J; Huang J
    World Neurosurg; 2019 Aug; 128():374-375. PubMed ID: 31136837
    [No Abstract]   [Full Text] [Related]  

  • 19. Does ARUBA study improve our knowledge as regards the management of unruptured brain arteriovenous malformations?
    Proust F; Roche PH; Meling TR
    Neurochirurgie; 2014; 60(1-2):2-4. PubMed ID: 24656262
    [No Abstract]   [Full Text] [Related]  

  • 20. Responses to ARUBA: a systematic review and critical analysis for the design of future arteriovenous malformation trials.
    Magro E; Gentric JC; Darsaut TE; Ziegler D; Msi ; Bojanowski MW; Raymond J
    J Neurosurg; 2017 Feb; 126(2):486-494. PubMed ID: 27128584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.